Aktie 855254 TEIJIN LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Teijin Limited

Aktien

855254

JP3544000007

3401

Verzögert Japan Exchange
Andere Börsenplätze
 08:00:00 02.05.2024 		% 5 Tage % 1. Jan.
1 534 JPY -0,55 % Intraday Chart für Teijin Limited +3,16 % +14,78 %
09.02. Teijin erzielt Gewinn in Q1-Q3 des Geschäftsjahres MT
08.02. Transcript : Teijin Limited, Q3 2024 Earnings Call, Feb 08, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Teijin Swings to Fiscal Q1-Q3 Profit
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024
Garwood Medical Devices, LLC announced that it has received funding from Teijin Limited, Pegasus Tech Ventures, Inc.
Teijin : Frontier announces development of Microft™ MX, a new material for sports and outdoor wear that evenly combines the texture and functionality of polyester and nylon
Teijin Limited - Notice Concerning a Decision on the Licensing Agreement related to the Three Hormone Therapy Drugs for Rare Endocrine Diseases
Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
Ascendis Pharma Announces Strategic Partnership with Teijin Limited in Japan
Ascendis Pharma A/S Announces Strategic Partnership with Teijin Limited in Japan
Teijin Limited Revises Earnings Guidance for the Year Ending March 31, 2024
Teijin : CEO Teijin Aramid, Peter ter Horst joins VNCI Board
Japan stocks retreat from 33-year peak ahead of Fed policy decision
Japan stocks retreat from 33-year peak ahead of Fed policy decision
Tipcomposite Co.,Ltd. signed a share transfer agreement to acquire a 99.1% stake in GH Craft Ltd. from Teijin Limited
Teijin : Tokyu Construction Co., Ltd. and Teijin Complete Successful Trial of Hydrogen Fuel Cell Generators to Supply Power at Shibuya Construction Site
Teijin Limited Provides Dividend Guidance for the Full Year Ending March 31, 2024
Teijin Limited Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024
Teijin Limited Provides Dividend Guidance for the End of Second Quarter of Full Year Ending March 31, 2024
Teijin : Notice Concerning Completion of Payment for the Disposal of Treasury Shares as “Restricted Stock”
Teijin and Axcelead to Establish Drug Discovery Research Joint Venture
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 855254 Aktie
  4. Nachrichten Teijin Limited
  5. Andere Sprachen